Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-13

Clinical Trial Update: Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing immunosuppressive therapy alone versus with oral anticoagulation for venous thrombotic involvement in Behçet's disease; status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Marmara University | Conditions: Behcet Disease, Behcet Disease and Vascular Involvement | Phase 3 | Status: NOT_YET_RECRUITING